Cantor Fitzgerald Reiterates Overweight on Aquinox Pharma (AQXP) Following 4Q
Tweet Send to a Friend
Cantor Fitzgerald reiterated an Overweight rating and $28.00 price target on Aquinox Pharmaceutical (NASDAQ: AQXP) following 4Q earnings report. QXP ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
